MedPath

Evaluation of Effectiveness and Safety of NOBORI Stent

Completed
Conditions
Coronary Artery Disease
Registration Number
NCT01348360
Lead Sponsor
Seung-Jung Park
Brief Summary

The objective of this study is to evaluate effectiveness and safety of Nobori stent in the "real world" daily practice as compared with first-generation drug-eluting stents (sirolimus- or paclitaxel-eluting stents).

Detailed Description

This study is a non-randomized, prospective, open-label registry to compare the efficacy and safety of NOBORI stents versus first-generation DES in patients with coronary artery disease.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
2000
Inclusion Criteria
  • Patients receiving NOBORI stents.
  • The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site.
Exclusion Criteria
  • Patients with a mixture of other DESs.
  • Terminal illness with life expectancy <1 year.
  • Patients with cardiogenic shock.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
composite of death, nonfatal myocardial infarction (MI), or ischemic-driven Target- Vessel Revascularization (TVR)12 months post procedure
Secondary Outcome Measures
NameTimeMethod
Death (all cause and cardiac)yearly up to 5 years
MIyearly up to 5 years
TVRyearly up to 5 years
Target-lesion revascularization (TLR)yearly up to 5 years
Stent thrombosis (ARC criteria)yearly up to 5 years
Composite of death or MIyearly up to 5 years
Procedural success (defined as achievement of a final diameter stenosis of <30% by visual estimation, without the occurrence of death, Q-wave MI, or urgent revascularization during the index hospitalization)At discharge from the index hospitalization
Composite of cardiac death or MIyearly and up to 5 years

Trial Locations

Locations (25)

Gangwon National Univ. Hospital

🇰🇷

Chuncheon, Korea, Republic of

Asan Medical Center

🇰🇷

GangNeung, Korea, Republic of

Soon Chun Hyang University Hospital Bucheon

🇰🇷

Bucheon, Korea, Republic of

The Catholic University of Korea, Bucheon ST.Mary's Hospital

🇰🇷

Bucheon, Korea, Republic of

Daegu Catholic University Medical Center

🇰🇷

Daegu, Korea, Republic of

Keimyung University Dongsan Medical Center

🇰🇷

Daegu, Korea, Republic of

The Catholic University of Korea, Daejeon ST. Mary's Hospital

🇰🇷

Daejeon, Korea, Republic of

Chonnam National University Hospital

🇰🇷

Gwangju, Korea, Republic of

DongGuk University Gyongju Hospital

🇰🇷

Gyeongju, Korea, Republic of

National Health Insurance Corporation Ilsan Hospital

🇰🇷

Ilsan, Korea, Republic of

Gachon University Gil Hospital

🇰🇷

Incheon, Korea, Republic of

Kwangju Christian Hospital

🇰🇷

Kwangju, Korea, Republic of

KangBuk Samsung Hospital

🇰🇷

Seoul, Korea, Republic of

Korea University Hospital

🇰🇷

Seoul, Korea, Republic of

Korea University Guro Hospital

🇰🇷

Seoul, Korea, Republic of

St. Mary's Catholic Medical Center

🇰🇷

Seoul, Korea, Republic of

Kyung Hee University Medical Hospital

🇰🇷

Seoul, Korea, Republic of

The Catholic University of Korea St.Paul's Hospital

🇰🇷

Seoul, Korea, Republic of

The Catholic University of Korea St. Vincent's Hospital

🇰🇷

Suwon, Korea, Republic of

The Catholic University of Korea Uijeongbu St. Mary's Hospital

🇰🇷

Uijeongbu, Korea, Republic of

Ulsan University Hospital

🇰🇷

Ulsan, Korea, Republic of

Yeungnam University Medical Center

🇰🇷

Daegu, Korea, Republic of

Inha University Hospital

🇰🇷

Incheon, Korea, Republic of

Chonbuk National University Hospital

🇰🇷

Jeonju, Korea, Republic of

The Catholic University of Korea Yeouido St.Mary's Hospital

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath